CDIO
NASDAQ · Biotechnology
Cardio Diagnostics Holdings
$1.97
+0.09 (+4.52%)
Open$1.86
Previous Close$1.88
Day High$1.99
Day Low$1.85
52W High$17.39
52W Low$0.97
Volume—
Avg Volume428.9K
Market Cap5.56M
P/E Ratio—
EPS$-3.72
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,580.9% upside
Current
$1.97
$1.97
Target
$33.03
$33.03
$21.42
$33.03 avg
$37.66
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.2K | 758.5K | 743.9K |
| Net Income | -10,980,222 | -209,998 | -203,473 |
| Profit Margin | -43,817.7% | -27.7% | -27.4% |
| EBITDA | -10,846,158 | -263,366 | -243,311 |
| Free Cash Flow | — | -217,938 | -231,433 |
| Rev Growth | — | -7.2% | +1.3% |
| Debt/Equity | 0.04 | 0.72 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |